Amal Therapeutics featured in September edition of BioPharma Dealmaker (Springer-Nature)

Geneva, Switzerland – 19 September 2018 – We are pleased to announce that AMAL Therapeutics is featured in the September edition of BioPharma Dealmakers (Nature Research), outlining the promise of protein-based therapeutics cancer vaccine in oncology.   View PDF

ESMO Geneva 13-16 Dec 2018

ESMO Immuno Oncology – Geneva 2018 13-16 December / Geneva / Switzerland Amal Therapeutics Team attending

IPO Day 13 June 2018

IPO Day Lausanne 2018 13 June / Lausanne / Switzerland Madiha Derouazi attending

BIO International Convention 2018

BIO International Convention 2018 4-7 June 2018 / Boston, MA / USA Madiha Derouazi attending

ASCO Annual Meeting 2018

ASCO Annual Meeting 2018 1-5 June 2018 / Chicago, IL / USA Patricia Delaite attending

16th CIMT Annual Meeting

16th CIMT Annual Meeting 15-17 May 2018 / Mainz / Germany Jean-François Mayol attending